Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xuanfei Baidu Granules (XFBD) in Persons With COVID-19
NCT04810689Phase 2Terminated
- Start
- Mar 2021
- Primary completion
- Jun 2022
- Modality
- TCM (Traditional Chinese Medicine)
- Countries
- 1
01
Overview
A Phase 2 trial of Xuanfei Baidu in coronavirus disease 2019 (COVID-19). Started Mar 2021; status: terminated.
02
Drugs
Xuanfei Baidu
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04810689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04810689.